EDSA — Edesa Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapSucker Stock

Annual balance sheet for Edesa Biotech, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	7.84	7.09	5.36	1.04	10.8
Net Total Accounts Receivable
Net Total Receivables	3.3	1.26	0.627	0.271	0.643
Prepaid Expenses
Total Current Assets	12.1	9.09	6.44	1.68	11.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.112	0.031	0.1	0.018	0
Net Intangible Assets
Other Long Term Assets
Total Assets	14.6	11.6	8.89	3.81	13.5
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.46	2.14	1.82	1.83	1.08
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.53	2.18	1.84	1.83	1.08
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	13.1	9.39	7.05	1.98	12.5
Total Liabilities & Shareholders' Equity	14.6	11.6	8.89	3.81	13.5
Total Common Shares Outstanding